You are in: EUROSPITAL / NEWS
29/08/2014 - DiabeGen

Eurospital is proud to announce the availability of DiabeGen I and II Step, presently the unique CE/IVD system for the detection of genetic predisposition, protection and risk assessment to develop o Type 1 Diabetes Mellitus (TD1)

 

Click on the image below to go to the product specifications page.

 

Eurospital Spa - Via Flavia 122 - 34147 Trieste - P.IVA: 00047510326 - C.S. € 2582000 CF e Reg. Impr. 00047510326 - REA TS 38955
Eurospital © 2018 - Privacy - Site credits